COVID-19 Update: All AMP Locations are open, see how we are offering safe in person care and virtual visits. Click here to Learn more about Virtual Care Options.

Due to high call volume, you may experience hold times that are longer than usual.

Non-Discrimination Notice

Sipuleucel-T for CRPC

The Rationale for Optimal Combination Therapy With Sipuleucel-T for Patients With Castration-resistant Prostate Cancer: Combining immunotherapy with other treatments may have potent anticancer effects. Understanding the interactions between different mCRPC treatments may offer further potential to improve patient outcomes.

For more information read the entire Article

This article was Co-written by some of the Physicians of Associated Medical Professionals of NY, PLLC: Vladimir Mouraviev MD, Neil Mariados MD, David Albala MD & Christopher Pieczonka MD